Management of complicated parapneumonic effusions
Sign Up to like & getrecommendations! Published in 2022 at "Current Opinion in Pulmonary Medicine"
DOI: 10.1097/mcp.0000000000000934
Abstract: Purpose of review Approximately 36–57% of cases of pneumonia are associated with a parapneumonic effusion (PPE). It begins as sterile effusion, which can quickly evolve to a fibrinopurulent stage with evidence of infection called complicated… read more here.
Keywords: management complicated; parapneumonic effusions; complicated parapneumonic; evidence ... See more keywords
Phase 1 trial of intrapleural LTI-01; single chain urokinase in complicated parapneumonic effusions or empyema.
Sign Up to like & getrecommendations! Published in 2019 at "JCI insight"
DOI: 10.1172/jci.insight.127470
Abstract: BACKGROUND Current dosing of intrapleural fibrinolytic therapy (IPFT) in adults with complicated parapneumonic effusion (CPE) / empyema is empiric, as dose-escalation trials have not previously been conducted. We hypothesized that LTI-01 (scuPA), which is relatively… read more here.
Keywords: trial; lti ipft; complicated parapneumonic; well tolerated ... See more keywords
A study of the proteomic expression in patients with complicated parapneumonic pleural effusion
Sign Up to like & getrecommendations! Published in 2021 at "Archives of Medical Science"
DOI: 10.5114/aoms/132885
Abstract: Introduction: The present study aimed to investigate the differences in the proteomic expression between uncomplicated parapneumonic pleural effusion (UPPE) and complicated parapneumonic pleural effusion (CPPE). Material and methods: There were 10 patients with UPPE and… read more here.
Keywords: parapneumonic pleural; complicated parapneumonic; effusion; pleural effusion ... See more keywords